SEAMLESS Trademark
Trademark Overview
On Thursday, December 14, 2023, a trademark application was filed for SEAMLESS with the United States Patent and Trademark Office. The USPTO has given the SEAMLESS trademark a serial number of 79408326. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Thursday, November 14, 2024. This trademark is owned by Seamless Therapeutics GmbH. The SEAMLESS trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical and biological preparations or active substances for the treatment of diseases; medical, pharmaceutical and biopharmaceutical preparations and substances for the treatment of diseases; pharmaceutical goods and preparations, namely gene transfer, regulation, modulation and delivery medications for the treatment of genetic diseases and disorders; products, agents, for medical purposes, for veterinary purposes; genome editable enzymes; DNA recombinant enzymes; DNA editable enzymes, especially, recombinases and integrases; genome editable enzymes for the treatment of diseases; DNA recombinant enzymes for the treatment of diseases; DNA editable enzymes, in particular recombinases and integrases, for the treatment of diseases.
Chemicals for use in industry and science; biological preparations, biological reagents, for use in industry and science.
Medical services; medical analysis relating to the treatment of persons; assay services, for treatment purposes; medical services and medical services, in relation to the following fields: genome editing; genetic counseling; therapy services; services for the preparation of medical reports; providing personalised healthcare and medical information; providing therapy recommendations; providing of information and counselling services, in relation to the following fields: medical services, health care services; therapy consultancy, in relation to the following fields: genome editing; counselling relating to recombinases and integrases for the treatment of diseases.
Medical apparatus and instruments; laboratory apparatus for medical diagnostic purposes.
Scientific and technological services and research, especially creation and application of bioinformatic algorithms and models; science and technology services, scientific and technological research, scientific development services, technological development, relating to the following sectors: gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; consultancy services relating to development of pharmaceutical and biological preparations or medications for humans in the field of gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy; genome engineering services; scientific research relating to genetics, scientific research, relating to the following sectors: genome editing; analytical laboratory services; medical laboratory services; scientific laboratory services; resear...
General Information
| Serial Number | 79408326 |
| Word Mark | SEAMLESS |
| Filing Date | Thursday, December 14, 2023 |
| Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
| Status Date | Thursday, November 14, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical and biological preparations or active substances for the treatment of diseases; medical, pharmaceutical and biopharmaceutical preparations and substances for the treatment of diseases; pharmaceutical goods and preparations, namely gene transfer, regulation, modulation and delivery medications for the treatment of genetic diseases and disorders; products, agents, for medical purposes, for veterinary purposes; genome editable enzymes; DNA recombinant enzymes; DNA editable enzymes, especially, recombinases and integrases; genome editable enzymes for the treatment of diseases; DNA recombinant enzymes for the treatment of diseases; DNA editable enzymes, in particular recombinases and integrases, for the treatment of diseases. |
| Goods and Services | Chemicals for use in industry and science; biological preparations, biological reagents, for use in industry and science. |
| Goods and Services | Medical services; medical analysis relating to the treatment of persons; assay services, for treatment purposes; medical services and medical services, in relation to the following fields: genome editing; genetic counseling; therapy services; services for the preparation of medical reports; providing personalised healthcare and medical information; providing therapy recommendations; providing of information and counselling services, in relation to the following fields: medical services, health care services; therapy consultancy, in relation to the following fields: genome editing; counselling relating to recombinases and integrases for the treatment of diseases. |
| Goods and Services | Medical apparatus and instruments; laboratory apparatus for medical diagnostic purposes. |
| Goods and Services | Scientific and technological services and research, especially creation and application of bioinformatic algorithms and models; science and technology services, scientific and technological research, scientific development services, technological development, relating to the following sectors: gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; consultancy services relating to development of pharmaceutical and biological preparations or medications for humans in the field of gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy; genome engineering services; scientific research relating to genetics, scientific research, relating to the following sectors: genome editing; analytical laboratory services; medical laboratory services; scientific laboratory services; research laboratories; scientific research and development; development of pharmaceutical preparations and medicines; pharmaceutical products development; bioinformatic research for identification of target sequences for genome editing in a cell's DNA; bioinformatic research for identification of target sequences for genome editing in a cell's DNA by genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases; bioinformatic or computational analysis to identify target sequences in a cell's DNA; screening processes for the identification of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases; research and development for the pharmaceutical industry; technological consultancy, relating to the following sectors: treatment of diseases by means of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases. |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Seamless Therapeutics GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 98 - Unknown |
| Address | DE |
Trademark Events
| Event Date | Event Description |
| Thursday, October 31, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, November 4, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 4, 2024 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, November 5, 2024 | ASSIGNED TO EXAMINER |
| Thursday, November 14, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, November 15, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
